24 Horton KC, Richards AS, Emery JC, et al. Re-evaluating progression and pathways following Mycobacteria tuberculosis infection within the spectrum of tuberculosis disease. medRxiv 2022 pre-print [DOI: https://doi. org/10.1101/2022.12.14.22283422]. 25 Dye C, Williams BG. Tuberculosis decline in populations affected by HIV: a retrospective study of 12 countries in the WHO African Region. Bull World Health Organ 2019 97: 405. 26 UNAIDS. Tuberculosis and HIV – Progress towards the 2020 target. Geneva, UNAIDS, 2019. 27 Prasad R, Gupta N, Banka A. Multidrug-resistant tuberculosis/rifampicin-resistant tuberculosis: principles of management. Lung India 2018 35: 78. 28 World Health Organization. Tuberculosis: Multidrug-resistant tuberculosis (MDR-TB). www.who.int/news-room/ questions-and-answers/item/tuberculosis-multidrug-resistant-tuberculosis-(mdr-tb) Date last accessed: 30 January 2023. 29 Soedarsono S, Mertaniasih NM, Kusmiati T, et al. Determinant factors for loss to follow-up in drug-resistant tuberculosis patients: the importance of psycho-social and economic aspects. BMC Pulm Med 2021 21: 1–8. 30 World Health Organization. Definitions and reporting framework for tuberculosis. Geneva, World Health Organization, 2013. 31 World Health Organization. Global Tuberculosis Report 2022: TB diagnosis &treatment. www.who.int/teams/ global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022/tb-diagnosis-treatment Date last accessed: 26 January 2023. 32 Hogan AB, Jewell BL, Sherrard-Smith E, et al. Potential impact of the COVID-19 pandemic on HIV, tuberculosis, and malaria in low-income and middle-income countries: a modelling study. Lancet Glob Health 2020 8: e1132–e1141. 33 The Global Fund. Tuberculosis: The Unseen Pandemic. www.theglobalfund.org/en/opinion/2023/2023-03-20- tuberculosis-the-unseen-pandemic/ Date last accessed: 2 June 2023. 34 World Health Organization. Global Tuberculosis Report 2022: COVID-19 and TB. www.who.int/teams/ global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022/covid-19-and-tb Date last accessed: 18 January 2023. 35 Stop TB Partnership. The impact of COVID-19 on the TB epidemic: a community perspective. www.stoptb.org/ impact-of-covid-19-tb-epidemic-community-perspective Date last accessed: 26 January 2023. 36 Zimmer AJ, Klinton JS, Oga-Omenka C, et al. Tuberculosis in times of COVID-19. J Epidemiol Community Health (1978) 2022 76: 310–316. 37 Sahu S, Wandwalo E, Arinaminpathy N. Exploring the impact of the COVID-19 pandemic on tuberculosis care and prevention. J Pediatric Infect Dis Soc 2022 11: 67–71. 38 Chakaya J, Petersen E, Nantanda R, et al. The WHO Global Tuberculosis 2021 Report – not so good news and turning the tide back to End TB. Int J Infect Dis 2022 124: S26. 39 TB/COVID-19 Global Study Group. Tuberculosis and COVID-19 co-infection: description of the global cohort. Eur Respir J 2022 59: 2102538. 40 World Health Organization. Immunization coverage. www.who.int/news-room/fact-sheets/detail/immunization- coverage Date last accessed: 26 January 2023. 41 World Health Organization. WHO Coronavirus (COVID-19) Dashboard. https://covid19.who.int/ Date last accessed: 27 January 2023. 42 Nguimkeu P, Tadadjeu S. Why is the number of COVID-19 cases lower than expected in Sub-Saharan Africa? A cross-sectional analysis of the role of demographic and geographic factors. World Dev 2021 138: 105251. 43 Bolcato M, Rodriguez D, Feola A, et al. COVID-19 pandemic and equal access to vaccines. Vaccines 2021 9: 538. 44 Duarte R, Lönnroth K, Carvalho C, et al. Tuberculosis, social determinants and co-morbidities (including HIV). Pulmonology 2018 24: 115–119. 45 World Health Organization. Global Tuberculosis report 2022: UHC &TB determinants. https://www.who.int/ teams/global-tuberculosis-programme/tb-reports/global-tuberculosis-report-2022/uhc-tb-determinants Date last accessed: 17 July 2023. 46 Lönnroth K, Jaramillo E, Williams BG, et al. Drivers of tuberculosis epidemics: the role of risk factors and social determinants. Soc Sci Med 2009 68: 2240–2246. 47 Lönnroth K, Castro KG, Chakaya JM, et al. Tuberculosis control and elimination 2010-50: cure, care, and social development. Lancet 2010 375: 1814–1829. 48 Jiamsakul A, Lee MP, Nguyen KV, et al. Socio-economic status and risk of tuberculosis: a case-control study of HIV-infected patients in Asia. Int J Tuberculosis Lung Dis 2018 22: 179–186. 49 Mahara G, Yang K, Chen S, et al. Socio-economic predictors and distribution of tuberculosis incidence in Beijing, China: a study using a combination of spatial statistics and GIS technology. Med Sci (Basel) 2018 6: 26. 50 Prats-Uribe A, Orcau A, Millet JP, et al. Impact of socio-economic inequities on tuberculosis in a Southern European city: what is the effect of the recession? Int J Tuberculosis Lung Dis 2019 23: 45–51. 51 Hargreaves JR, Boccia D, Evans CA, et al. The social determinants of tuberculosis: from evidence to action. Am J Public Health 2011 101: 654–662. 30 https://doi.org/10.1183/2312508X.10023922 ERS MONOGRAPH |THE CHALLENGE OF TB IN THE 21ST CENTURY